16 results
Variceal Screening Algorithm in Cirrhosis

#Variceal #Screening #Algorithm #cirrhosis #hepatology #endoscopy #EGD #management
Variceal Screening ... Algorithm in Cirrhosis ... #Variceal #Screening ... #hepatology #endoscopy ... #EGD #management
Screening and surveillance of varices in patients with cirrhosis. 

- No for screening need if platelets
Screening and surveillance ... patients with cirrhosis ... - No for screening ... fulltext #varices #Variceal ... #Hepatology #EGD
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
Beta-Blockers in Cirrhosis ... Prevention of first variceal ... Prevention of variceal ... #hepatology #management ... #pharmacology #
Variceal Screening Algorithm in Cirrhosis
No varices -> repeat 2-3 years 
Small varices->repeat 1-2 years unless child
Variceal Screening ... Algorithm in Cirrhosis ... #Screening #Algorithm ... #EGD #varices # ... hepatology #endoscopy
 End Stage Liver Disease (Cirrhosis) - Complications 
 • Ascites
 • Esophageal Varices
 • Hepatic
End Stage Liver ... Disease (Cirrhosis ... #ESLD #Liver #Cirrhosis ... Complications #diagnosis #management ... #summary #hepatology
VIBES Mnemonic - Cirrhosis Management Checklist

V - Volume (Ascites, HRS)
	- Evaluate for Ascites, Edema, Hydrothorax, Hepatorenal
VIBES Mnemonic - Cirrhosis ... Management Checklist ... PPI, octreotide, EGD ... S - Screening (HCC ... #Diagnosis #Hepatology
Hepatocellular Carcinoma (HCC) in Cirrhosis - Management Algorithm

Very early (0) - Single <2 cm, Preserved liver
Carcinoma (HCC) in Cirrhosis ... - Management Algorithm ... transplantable HCC, End-stage ... #Management #Algorithm ... #hepatology
Esophageal Variceal Bleeding - Diagnosis and Management Summary
PRE-ENDOSCOPY
Vasoactive agents - Octreotide: 
 • 50mcg bolus →
Diagnosis and Management ... ligation - EGD ... Surveillance EGD ... Bleeding #Diagnosis #Management ... endoscopy #varices #hepatology
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
patients with cirrhosis ... #UseDisorder #Management ... AUD #Therapies #Screening ... #Medications #Pharmacology
The 6 C’s of Primary Sclerosing Cholangitis (PSC)
PSC is a chronic, cholestatic, immune-mediated disease characterized by
CIRRHOSIS - ... Progression to cirrhosis ... liver disease management ... Cholangitis #diagnosis #management ... #summary #Hepatology